CLR Berlin took the Gold Innovation Award for Actives yesterday for the company's balancing and inflammation-reducing ingredient, AnnonaSense CLR.
CLR Berlin's global sales and marketing director, John Lofthouse, said to Personal Care: "We are very pleased the science behind the product has been recognised. From a marketing point of view it is very on-trend with the surge in CBD-related products, so it is good that the hard work from our R&D and marketing team has been justified."
Obtained from the Cherimoya fruit from South America, AnnonaSense CLR provides the skin with means to establish a sustainable homeostatic balance, improving skin health and well-being. The potent adaptogenic action of AnnonaSense CLR supports the skin’s endocannabinoid system by activating the CB2 receptor. Through this action, it reduces inflammatory processes induced by TRPV1. Histamine-, as well as TNFα/Substance P-induced stress is down-regulated and the expression of a vital detrimental receptor in skin, IL-31RA, is decreased. AnnonaSense CLR makes the skin less sensitive and more balanced, even itch is perceivably reduced. Skin appearance is improved and the perception of well-being and quality of life is enhanced.
